Finally, a recent study investigated the effects of ascorbate on cell growth and differentiation of SKM-1 AML cell line, harbouring both TET2 and TP53 mutations, showing a beneficial anti-proliferative effect also in this subgroup of adverse-risk AML (Smith-Díaz et al., 2021). This evidence concerns the gene TET2 and acute myeloid leukemia.